- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03475966
Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program
Improving Outcomes in Patients With Hepatobiliary and Pancreatic Cancers With a Nutritional and Physical Conditioning Prehabilitation Program
Major surgery is a stressful procedure; good recovery after surgery is important to patients and their doctors. Studies done at the McGill University Health Centre (MUHC) with cancer patients awaiting surgery have shown that exercise combined with simple diet recommendations (which may include a supplement) and relaxation techniques before surgery helped speed up the ability to resume walking after surgery.
These results have made the investigators aware that exercise and good nutrition are as important before surgery as they are after surgery; while it is common practice to start strengthening the body after surgery (rehabilitation), there may be some advantage to begin this process before surgery (prehabilitation).
The purpose of this study is to see if the following program, either before or after surgery, can help patients recover from liver, pancreas or bile duct surgery:
- Exercise that may help participants move and breath better,
- Nutrition advice and a supplement to make participants strong,
- Relaxation and anti-anxiety tips to help cope with the stress of upcoming surgery
The investigators will see if following this program will have an effect on participants' ability to walk before and after surgery.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Quebec
-
Montreal, Quebec, Canada, H4A 3S5
- Recruiting
- McGill University Health Centre
-
Contact:
- Antonio Vigano, MD, MSc
- Phone Number: 78716 514-934-1934
- Email: antonio.vigano@mcgill.ca
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria:
- A diagnosis or suspicion of either hepatobiliary or pancreatic cancer (primary or metastatic)
- Must be scheduled for surgical resection between 4-6 weeks of recruitment
Exclusion criteria:
- Persons with American Society of Anesthesiologists (ASA) health status class 4-5
- Comorbid medical, physical and mental conditions (eg: dementia, disabling orthopedic and neuromuscular disease, psychosis)
- Cardiac abnormalities
- Severe end-organ disease such as cardiac failure, chronic obstructive pulmonary failure and hepatic failure (alanine aminotransferase and aspartate aminotransferase >50% over the normal range)
- Sepsis
- Morbid obesity (BMI >40)
- Anemia (hematocrit <30 %)
- Other conditions interfering with the ability to perform exercise at home or to complete the testing procedures
- Poor English or French comprehension
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Prehabilitation
Exercise, nutrition and relaxation techniques all beginning four weeks prior to surgery date.
|
A kinesiologist will provide each patient wih an individualized home-based exercise program including aerobic, resistance and stretching exercises.
Patients will also exercise at our clinic once per week under the supervision of the kinesiologist (prehabilitation arm only)
Patients will be asked to fill in a 3-day food diary.
A registered dietitian (RD) will review this diary, provide a full nutritional assessment, and ensure patients are following a high-protein diet (1.5 g of protein/kg/day).
A whey-protein supplement may be provided to patients, should they require it.
The RD will also ensure adequate calorie consumption for weight maintenance and will provided advice to help ease any GI issues the patients may be experiencing.
Patients will see a psychologist who will provide relaxation techniques (eg.
imagery, visualization, deep breathing exercises) to help patients manage anxiety prior to surgery.
|
|
ACTIVE_COMPARATOR: Rehabilitation
Exercise, nutrition and relaxation techniques all beginning immediately after surgery.
|
A kinesiologist will provide each patient wih an individualized home-based exercise program including aerobic, resistance and stretching exercises.
Patients will also exercise at our clinic once per week under the supervision of the kinesiologist (prehabilitation arm only)
Patients will be asked to fill in a 3-day food diary.
A registered dietitian (RD) will review this diary, provide a full nutritional assessment, and ensure patients are following a high-protein diet (1.5 g of protein/kg/day).
A whey-protein supplement may be provided to patients, should they require it.
The RD will also ensure adequate calorie consumption for weight maintenance and will provided advice to help ease any GI issues the patients may be experiencing.
Patients will see a psychologist who will provide relaxation techniques (eg.
imagery, visualization, deep breathing exercises) to help patients manage anxiety prior to surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in functional walking capacity as measured by the six-minute walk test (6MWT)
Time Frame: Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
The 6MWT evaluates the ability of an individual to maintain a moderate level of physical activity over a time period reflective of the activities of daily living.
Subjects are instructed to walk back and forth, in a 20 meter stretch of hallway, for six minutes, at a pace that would make them tired by the end of the walk; encouragement and feedback are given according to published guidelines.
They are allowed to rest during the test if needed, but this time is included in the 6 minutes.
Reference equations are available for calculating percent of age- and gender-specific norm.
|
Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Timed up and go test
Time Frame: Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
Investigators will measure the time required for a participant to stand up from being seated, walk a distance of 3 metres, turn around and walk back to the chair, and sit down.
This measure will be administered based on Canadian Society for Exercise Physiology standards.
|
Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
|
30-second sit to stand test
Time Frame: Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
Investigators will measure the number of times participants can stand from a seated position in 30-seconds.
This measure will be administered based on Canadian Society for Exercise Physiology standards.
|
Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
|
30-second arm curl test
Time Frame: Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
Investigators will measure the number of times participants can perform a full arm curl in 30-seconds.
Both arms will be assessed, one at a time.
This measure will be administered based on Canadian Society for Exercise Physiology standards.
|
Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
|
Change in handgrip strength
Time Frame: Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
To be measured using the Jamar hydraulic hand dynamometer.
Two measures from each hand will be taken, with patient seated and arm bent at a 90-degree angle.
The average of the two measures for each hand will be recorded and compared to normative data.
|
Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
|
Change in body composition
Time Frame: Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
Body composition will be measured via dual-energy X-ray absorptiometry (DXA; Lunar Prodigy Advance, General Electric Healthcare, Madison, WI).
Studies from the McGill Nutrition and Performance Laboratory group have validated the use of DXA in advanced cancer patients.
|
Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
|
Assessment of food intake and change over study period
Time Frame: Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
Participants will be asked to bring a 3-day food diary to their baseline visit to obtain detailed information about the quantity and type of food and beverages consumed during a non-consecutive 3-day period.
Overall energy intake, as well as macronutrient distribution (e.g., amount of carbohydrates, fats, proteins, and fibre at each meal) will be calculated using the Food Processor SQL Nutrition Analysis software.
|
Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
|
Perioperative data
Time Frame: 7 days post-operatively
|
This data will include operative characteristics, transfusion rates, length of surgery, intraoperative complications and length of stay.
|
7 days post-operatively
|
|
Postoperative complications
Time Frame: 4 weeks post-operatively
|
Including surgical site infection, other infectious complications (such as pneumonia, urinary tract infection, line sepsis), bile leak, hemorrhage, deep vein thrombosis, etc., will be recorded and scored using the Clavien Classification.
|
4 weeks post-operatively
|
|
Health-related quality of life (HRQL) - assessment of change over time
Time Frame: Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
As measured by the acute (1 week recall period) Functional Assessment of Cancer Therapy (FACT) survey.
This questionnaire also has versions that identify symptoms more specific to hepatobiliary and colorectal cancer patients; this is of relevance to this study given liver metastasis occurs in these patients.
The questionnaire is separated into five subscales: 1) physical well-being, 2) social/family well-being, 3) emotional well-being, 4) functional well-being, 5) additional concerns (specific to cancer type).
Each question is scored 0-4 on a likert scale, with 0 indicating, "not at all," and 4 indicating, "very much."
These scores are then reversed where applicable and added.
A higher score indicates better QoL.
|
Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
|
The Edmonton Symptom Assessment System (ESAS) - assessment of change over time
Time Frame: Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
Currently used at the MUHC Cedars Cancer Centre to assist in the assessment of pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, well-being, and shortness of breath.
Each symptom is rated from 0 to 10 on a numerical scale based on severity, with 0 indicating that the symptom is absent and 10 that it is the worst possible severity.
|
Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
|
Physical activity level - assessment of change over time
Time Frame: Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
Will be measured through the Community Health Activities Model Program for Seniors (CHAMPS) questionnaire.
The CHAMPS is a self-reported measure of physical activity, comprising 41 activities evaluated according to the total number of hours done during an average week.
Each physical activity is assigned a metabolic equivalent (MET) value yielding average weekly caloric expenditure for the listed physical activities.
There is evidence for the validity of CHAMPS as a measure of postoperative recovery.
Data will be categorized as either mild, moderate or intense activity and changes in the number of hours spent performing activities within each category will be assessed.
|
Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
|
Nutritional status - assessment of change over time
Time Frame: Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
To be assessed using the Abridged Patient-Generated Subjective Global Assessment (aPG-SGA); a validated questionnaire used to assess the nutritional and functional status of cancer patients.
The scoring system allows patients at risk for malnutrition to be identified and triaged for nutritional intervention.
The aPG-SGA may also be useful in monitoring short-term changes in nutritional status.
A score ≥9 indicates a critical need for nutritional intervention.
|
Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
|
Fatigue - assessment of change over time
Time Frame: Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
To be assessed using a visual analog scale (1-10) and the Brief Fatigue Inventory (BFI).
The BFI assesses the level of fatigue and its impact on activities of daily living.
The test has 9 questions: three questions are designed to assess the patient's fatigue during the immediate waking hours and 6 questions address how fatigue has interfered in the patient's life over the previous 24 hours.
Each question uses a scale rating from "0" (no fatigue) to "10" (unimaginable fatigue) for a total of 90 points.
|
Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
|
Weight - assessment of change over time
Time Frame: Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
Body weight will be measured (Kg)
|
Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
|
Height
Time Frame: Baseline
|
Height will be measured with a stadiometer (m)
|
Baseline
|
|
Body mass index - assessment of change over time
Time Frame: Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
Calculated wt (kg)/ht^2 (m)
|
Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
|
Blood pressure - assessment of change over time
Time Frame: Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
Systolic and diastolic at rest (mmHg)
|
Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
|
Heart rate - assessment of change over time
Time Frame: Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
Beats per minute measured using a pulse oximeter
|
Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lower extremity strength - assessment of change over time
Time Frame: Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
Optional measure: assessed using the Biodex System 3 (Biodex Medical Systems, Shirley, NY).
|
Baseline, pre-operative assessment, 4 weeks post-operative, 8 weeks post-operative
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Antonio Vigano, MD, MSc, McGill University Health Centre/Research Institute of the McGill University Health Centre
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Neoplasms by Histologic Type
- Neoplasms
- Neoplasms by Site
- Adenocarcinoma
- Carcinoma
- Neoplasms, Glandular and Epithelial
- Endocrine System Diseases
- Digestive System Neoplasms
- Endocrine Gland Neoplasms
- Biliary Tract Diseases
- Pancreatic Diseases
- Bile Duct Diseases
- Biliary Tract Neoplasms
- Pancreatic Neoplasms
- Cholangiocarcinoma
- Bile Duct Neoplasms
Other Study ID Numbers
- prehab_pilot
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pancreatic Cancer
-
City of Hope Medical CenterRecruitingPancreatic Neoplasms | Pancreatic Cancer | Pancreatic Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Pancreatic Cancer Resectable | Pancreatic Carcinoma | Pancreatic Cancer Non-resectable | Pancreatic Cancer Stage III | Pancreatic Cancer Stage | Pancreatic Cancer Stage II | Pancreatic Cancer, Adult | Pancreatic... and other conditionsUnited States, Japan, South Korea
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CelgeneWithdrawnPancreatic Ductal Adenocarcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
The First Affiliated Hospital with Nanjing Medical...Peking University Cancer Hospital & InstituteNot yet recruiting
-
Tianjin Medical University Cancer Institute and...Not yet recruiting
-
University of NebraskaNational Cancer Institute (NCI)CompletedPancreatic Adenocarcinoma | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage II Pancreatic Cancer | Stage I Pancreatic Cancer | Resectable Pancreatic Carcinoma | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
University of UtahNovartis Pharmaceuticals; Huntsman Cancer InstituteTerminatedMetastatic Pancreatic Carcinoma | Unresectable Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage II Pancreatic CancerUnited States
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedPancreatic Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingPancreatic Cancer | Pancreatic Cancer Metastatic | Pancreatic Cancer Stage IV | Metastatic Pancreatic Carcinoma | Metastatic Pancreatic Adenocarcinoma | Pancreatic Carcinoma | Metastatic Pancreatic Cancer | Pancreatic Cancer Non-resectable | Metastatic Pancreatic Ductal Adenocarcinoma | Pancreatic Carcinoma... and other conditionsUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedPancreatic Adenocarcinoma | Resectable Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic Cancer | Poorly Differentiated Malignant Neoplasm | Undifferentiated Pancreatic CarcinomaUnited States
-
University of Wisconsin, MadisonCompletedStage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
Clinical Trials on Exercise
-
National Institute of Neurological Disorders and...TerminatedTraumatic Brain InjuryUnited States
-
University of Texas, El PasoRecruitingKnee Osteoarthritis | Knee Pain Chronic | Central Pain SyndromeUnited States
-
Aksaray University Training and Research HospitalCompletedExercise Training | Lactate Blood Increase | Cognitive Functions | BDNFTurkey (Türkiye)
-
University of Alabama at BirminghamCompletedCystic FibrosisUnited States
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada
-
University of LisbonFundação para a Ciência e a TecnologiaActive, not recruiting
-
University of Missouri-ColumbiaCompleted
-
University of AlcalaCompletedMyofascial Pain | Myofascial Pain Syndrome | Post Needling Soreness | Myofascial Trigger Point PainSpain
-
Bayero University Kano, NigeriaCompletedChronic Low Back PainNigeria
-
University College CorkRecruitingDepressive Disorder, MajorIreland